An Estimate of the Worldwide Prevalence and Direct Costs of Dementia in 2003
@article{Wimo2006AnEO, title={An Estimate of the Worldwide Prevalence and Direct Costs of Dementia in 2003}, author={Anders Wimo and Linus Jonsson and Bengt Winblad}, journal={Dementia and Geriatric Cognitive Disorders}, year={2006}, volume={21}, pages={175 - 181} }
Dementia disorders are today considered to be a major driver of costs in health care and social systems and worrying estimates of future dementia prevalence have been presented. It is of great interest for policy makers to have an estimate of dementia disorders’ contribution to global social and health care costs, particularly in light of the demographic prognoses. The worldwide costs of dementia were estimated from prevalence figures for different regions, and cost-of-illness studies from key…
305 Citations
Featured Articles The worldwide economic impact of dementia 2010
- Medicine, Political Science
- 2013
Worldwide costs of dementia are enormous and distributed inequitably; there is considerable potential for cost increases in coming years as the diagnosis and treatment gap is reduced and future societal costs are anticipated and managed.
The economic burden of dementia in low- and middle-income countries (LMICs): a systematic review
- Medicine, Political ScienceBMJ Global Health
- 2022
The estimated costs of dementia in LMICs are lower than in high-income countries, and indirect costs contribute the most to the LMIC cost.
Medication cost of persons with dementia in primary care in Germany.
- Medicine, Political ScienceJournal of Alzheimer's disease : JAD
- 2014
Medication cost increases with the number of diagnoses and growing deficits in activities of daily living and decreases with age, while the current price reduction of anti-dementia drugs due to implementation of low-priced generics is estimated.
Costo monetario del tratamiento de la enfermedad de Alzheimer en Colombia
- Medicine, Political Science
- 2014
The cost estimates presented show that Alzheimer's disease will have a high cost to the Colombian society as access to treatment increases, and allow to identify that the estimates of models that assume a constant relationship between cost-of-illness and GDP per-capita tend to underestimate the financial burden.
Future costs of dementia-related long-term care: exploring future scenarios
- MedicineInternational Psychogeriatrics
- 2010
ABSTRACT Background: This study explores how the views of a panel of experts on dementia would affect projected long-term care expenditure for older people with dementia in England in the year 2031.…
Actual expense associated with patients with Alzheimer's disease in Colombia
- MedicineInternational Psychogeriatrics
- 2017
Worldwide costs of dementia estimates may be underestimating the actual costs to health systems in the developing world because of the presence of other comorbidities.
The Worldwide Challenge of the Dementias: A Role for B Vitamins and Homocysteine?
- MedicineFood and nutrition bulletin
- 2008
Large-scale randomized trials of homocysteine-lowering vitamins are needed to see if a proportion of dementia in the world can be prevented, and a definite causal pathway has yet to be shown.
Global and regional spending on dementia care from 2000–2019 and expected future health spending scenarios from 2020–2050: An economic modelling exercise
- Medicine, Political ScienceEClinicalMedicine
- 2022
Healthcare resource utilization and cost in dementia: are there differences between patients screened positive for dementia with and those without a formal diagnosis of dementia in primary care in Germany? ‡
- Medicine, Political ScienceInternational Psychogeriatrics
- 2015
Dementia diagnosis is beneficial for receiving cost-intensive anti-dementia drug treatments, but is currently insufficient to ensure adequate non-medication treatment for community-dwelling patients.
The Cost of Dementia in Europe
- Medicine, Political SciencePharmacoEconomics
- 2012
The current level of data availability regarding the costs of AD in Europe is described, findings from previous studies in different countries are summarized, and the applicability of available data for modelling purposes is discussed.
References
SHOWING 1-10 OF 53 REFERENCES
Costs of dementia in England and Wales in the 21st century
- Medicine, Political ScienceBritish Journal of Psychiatry
- 2001
Future increases in the population aged 65 years or over lead to rising formal care costs, however, the magnitude of cost changes depends on assumptions over dementia prevalence and levels of mental and physical functioning.
The Magnitude of Dementia Occurrence in the World
- MedicineAlzheimer disease and associated disorders
- 2003
The majority of demented elders live in less developed regions, and this proportion will increase considerably in the future, according to the forecast.
The US economic and social costs of Alzheimer's disease revisited.
- MedicineAmerican journal of public health
- 1994
New national prevalence estimates of the economic and social costs of Alzheimer's disease are presented and the estimated discounted present values of the direct and total costs of all current and future generations of Alzheimer’s patients are $536 billion and $1.75 trillion.
Net economic costs of dementia in Canada.
- Medicine, Political ScienceCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
- 1994
The annual net economic cost of dementia in Canada is at least $3.9 billion, and the most significant component of the total cost was for care in long-term care institutions and for assistance with ADLs by professionals, family and friends in the community.
The economic and social cost of dementia in Ireland
- Medicine, Political ScienceInternational journal of geriatric psychiatry
- 2000
The critical role of carers in maintaining people with dementia in their own home is reflected in the results showing that family care accounts for almost 50% of the overall resource burden, based on an opportunity cost valuation of carer time.
[Direct and indirect diabetes costs in the world].
- MedicineMedicina
- 2004
The goal of this paper is to review the studies on the costs of diabetes, to identify the strengths and limitations of currently available diabetes cost studies, and to identify future research areas that will help to better understand the economic burden of diabetes.
Epidemiology of dementia.
- Medicine, PsychologyAnnales de medecine interne
- 1998
An integrative analysis of 47 surveys across 17 countries has suggested approximate rates under 1% for dementia from any cause in persons aged 60 to 69 years, rising to about 39% in persons 90 to 95 years old.
The Cost of Dementia in Denmark: The Odense Study
- Medicine, PsychologyDementia and Geriatric Cognitive Disorders
- 1999
In a population-based study of dementia, the cost of care for 245 demented elderly and 490 controls matched by age and gender was estimated and except for very mild dementia the cost did not differ between elderly who suffer from Alzheimer’s disease and those with other types of dementia.
Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group.
- Medicine, PsychologyNeurology
- 2000
Dementia is more prevalent in women, and AD is the main contributor to the steep increase of prevalence with age, so a large variation across studies was observed, as well as a difference in prevalence between men and women that was age dependent.
The Prevalence and Costs of Psychiatric Disorders and Learning Disabilities
- Medicine, PsychologyBritish Journal of Psychiatry
- 1995
The findings show that learning disability, schizophrenia and neurotic conditions (including depression) are major burdens on the National Health Service; senile dementia and depression in older people impact largely on local authority social services.